Stocks

CVS Health Reported Another Stellar Quarter Despite Busy Acquisitions, but Disappointed by Guidance

 Stocks

CVS Health (CVS) stock is retreating more than 1.5% in premarket trading, being mostly affected by uncertainties over Fed’s rate decision tonight, rather than its freshly published quarterly results showing total revenues of $85.28 billion posted an 11% annual increase over the $76.83 billion.

May 3, 2023

views 1427

Popular posts

Stocks

Apple February MoM iPhone Sales down 9% in U.S., 16% in China.

April 1, 2024

views 2975
Cryptocurrencies

Elon Musk's Tesla has Added a Dogcoin (DOGE) Payment Form to its Website. The Meme Coin Soars.

May 6, 2024

views 2968
Stocks

JPMorgan's Q1 Revenue Up by 9% to $41.93 Billion, but Guidance Disappointed

April 12, 2024

views 2887
Commodities

Global Grain Price Recoveries Appears Excessively Bullish vis-à-vis Inventories and Weather Factors

April 24, 2024

views 2867
Currencies

USD May Return to Strengthening on Disappointing Inflation Report

April 10, 2024

views 2818
show more

Tech summary box

top crypto

© 2024 DRT

Client Agreement AML Policy Refund and Withdrawal policy Privacy Policy

Trading financial instruments involves substantial risk and is not suitable for all investors. The information herein is not a recommendation to trade nor investment research or an offer to buy or sell any instrument. It does not take into account your particular investment objectives, financial situation or needs and does not create a binding obligation on any of the Dr Trade Company to enter into any transaction with you. You are advised to perform an independent investigation of any transaction to determine whether any transaction is suitable for you.